Severe active refractory ulcerative colitis is a potentially life-threatening disease. The introduction of intensive steroid treatment and early surgery has reduced mortality in recent years. Ciclosporin and infliximab are effective rescue therapies in steroid refractory colitis. A head-to-head study proposed by Laharie et al. failed to demonstrate the superiority of ciclosporin but confirmed the efficacy and safety of infliximab to control active disease and to maintain remission
Rizzello F, Praticò C, Calabrese C, Gionchetti P (2013). Rescue therapy: ciclosporin or infliximab?. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 9, 503-505 [10.1586/eci.13.34].
Rescue therapy: ciclosporin or infliximab?
RIZZELLO, FERNANDO;PRATICÒ, CHIARA;CALABRESE, CARLO;GIONCHETTI, PAOLO
2013
Abstract
Severe active refractory ulcerative colitis is a potentially life-threatening disease. The introduction of intensive steroid treatment and early surgery has reduced mortality in recent years. Ciclosporin and infliximab are effective rescue therapies in steroid refractory colitis. A head-to-head study proposed by Laharie et al. failed to demonstrate the superiority of ciclosporin but confirmed the efficacy and safety of infliximab to control active disease and to maintain remissionI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
